These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 33882129)

  • 1. Assessment of calciprotein particle formation by AUC of the absorbance change: effect of FYB-931, a novel bisphosphonate compound.
    Ishida K; Ashizawa N; Morikane S; Kurita N; Kobashi S; Iwanaga T
    J Pharm Pharmacol; 2021 Jun; 73(7):947-955. PubMed ID: 33882129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel bisphosphonate compound FYB-931 preferentially inhibits aortic calcification in vitamin D3-treated rats.
    Ishida K; Ashizawa N; Matsumoto K; Kobashi S; Kurita N; Shigematsu T; Iwanaga T
    J Bone Miner Metab; 2019 Sep; 37(5):796-804. PubMed ID: 30712064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bisphosphonate FYB-931 Prevents High Phosphate-Induced Vascular Calcification in Rat Aortic Rings by Altering the Dynamics of the Transformation of Calciprotein Particles.
    Kawakami K; Ohya M; Yashiro M; Sonou T; Yamamoto S; Nakashima Y; Yano T; Tanaka Y; Ishida K; Kobashi S; Shigematsu T; Araki SI
    Calcif Tissue Int; 2023 Aug; 113(2):216-228. PubMed ID: 37099142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lead Acetate-Injected Mice is an Animal Model for Extrapolation of Calcifying Response to Humans Due to Low Involvement of Bone Resorption.
    Morikane S; Ishida K; Ashizawa N; Taniguchi T; Matsubayashi M; Kurita N; Kobashi S; Iwanaga T
    Calcif Tissue Int; 2024 Sep; 115(3):315-327. PubMed ID: 38951181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calciprotein particle inhibition explains magnesium-mediated protection against vascular calcification.
    Ter Braake AD; Eelderink C; Zeper LW; Pasch A; Bakker SJL; de Borst MH; Hoenderop JGJ; de Baaij JHF
    Nephrol Dial Transplant; 2020 May; 35(5):765-773. PubMed ID: 31605492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calciprotein Particle Synthesis Strategy Determines In Vitro Calcification Potential.
    Zeper LW; Smith ER; Ter Braake AD; Tinnemans PT; de Baaij JHF; Hoenderop JGJ
    Calcif Tissue Int; 2023 Jan; 112(1):103-117. PubMed ID: 36326853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel assessments of systemic calcification propensity.
    Pasch A
    Curr Opin Nephrol Hypertens; 2016 Jul; 25(4):278-84. PubMed ID: 27228365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnesium and calciprotein particles in vascular calcification: the good cop and the bad cop.
    Zeper LW; de Baaij JHF
    Curr Opin Nephrol Hypertens; 2019 Jul; 28(4):368-374. PubMed ID: 31045659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual Effects of Bisphosphonates on Ectopic Skin and Vascular Soft Tissue Mineralization versus Bone Microarchitecture in a Mouse Model of Generalized Arterial Calcification of Infancy.
    Li Q; Kingman J; Sundberg JP; Levine MA; Uitto J
    J Invest Dermatol; 2016 Jan; 136(1):275-283. PubMed ID: 26763447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium phosphate microcrystallopathy as a paradigm of chronic kidney disease progression.
    Kuro-O M
    Curr Opin Nephrol Hypertens; 2023 Jul; 32(4):344-351. PubMed ID: 37074676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcification of vascular smooth muscle cells is induced by secondary calciprotein particles and enhanced by tumor necrosis factor-α.
    Aghagolzadeh P; Bachtler M; Bijarnia R; Jackson C; Smith ER; Odermatt A; Radpour R; Pasch A
    Atherosclerosis; 2016 Aug; 251():404-414. PubMed ID: 27289275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of Calciprotein Particles (CPPs) in Serum/Plasma Samples Using a Fluorescent Bisphosphonate.
    Miura Y; Kurosu H; Kuro-O M
    Methods Mol Biol; 2023; 2664():333-341. PubMed ID: 37423998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the phosphate binder sucroferric oxyhydroxide in dialysis patients on endogenous calciprotein particles, inflammation, and vascular cells.
    Thiem U; Hewitson TD; Toussaint ND; Holt SG; Haller MC; Pasch A; Cejka D; Smith ER
    Nephrol Dial Transplant; 2023 May; 38(5):1282-1296. PubMed ID: 36107466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of bisphosphonates on vascular calcification and bone metabolism in experimental renal failure.
    Lomashvili KA; Monier-Faugere MC; Wang X; Malluche HH; O'Neill WC
    Kidney Int; 2009 Mar; 75(6):617-25. PubMed ID: 19129793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients with advanced chronic kidney disease and vascular calcification have a large hydrodynamic radius of secondary calciprotein particles.
    Chen W; Anokhina V; Dieudonne G; Abramowitz MK; Kashyap R; Yan C; Wu TT; de Mesy Bentley KL; Miller BL; Bushinsky DA
    Nephrol Dial Transplant; 2019 Jun; 34(6):992-1000. PubMed ID: 29788425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects for inflammatory responses by CPP with different colloidal properties in hemodialysis patients.
    Mukai H; Miura Y; Kotani K; Kotoda A; Kurosu H; Yamada T; Kuro-O M; Iwazu Y
    Sci Rep; 2022 Dec; 12(1):21856. PubMed ID: 36528732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study on biorelevant calciprotein particles: Effect of stabilizing agents on the formation and crystallization mechanisms.
    Gelli R; Pucci V; Ridi F; Baglioni P
    J Colloid Interface Sci; 2022 Aug; 620():431-441. PubMed ID: 35439694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum calcification propensity predicts all-cause mortality in predialysis CKD.
    Smith ER; Ford ML; Tomlinson LA; Bodenham E; McMahon LP; Farese S; Rajkumar C; Holt SG; Pasch A
    J Am Soc Nephrol; 2014 Feb; 25(2):339-48. PubMed ID: 24179171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Live Imaging of Calciprotein Particle Clearance and Receptor Mediated Uptake: Role of Calciprotein Monomers.
    Koeppert S; Ghallab A; Peglow S; Winkler CF; Graeber S; Büscher A; Hengstler JG; Jahnen-Dechent W
    Front Cell Dev Biol; 2021; 9():633925. PubMed ID: 33996793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of increasing dialysate magnesium on calciprotein particles, inflammation and bone markers: post hoc analysis from a randomized controlled clinical trial.
    Bressendorff I; Hansen D; Pasch A; Holt SG; Schou M; Brandi L; Smith ER
    Nephrol Dial Transplant; 2021 Mar; 36(4):713-721. PubMed ID: 31764984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.